Confirmation of hydrazone formation in HYNIC-peptide conjugate preparation, and its hydrolysis during labeling with 99mTc

被引:10
作者
Gandomkar, M. [1 ]
Najafi, R.
Shafie, M.
Ebrahimi, S. E. S.
机构
[1] Atom Energy Org Iran, Nucl Res Ctr, Radioisotope Div, Tehran, Iran
[2] Univ Tehran Med Sci, Fac Pharm, Dept Med Chem, Tehran, Iran
关键词
technetium-99m; HYNIC; peptides; hydrazones; labeling;
D O I
10.1016/j.apradiso.2007.03.002
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Because of its monodenticity, 6-hydrazinopyridine-3-carboxylic acid (HYNIC) is of interest as a bifunctional chelator for labeling peptide with Tc-99m. Here, we confirm the formation of hydrazone in HYNIC-conjugated peptide. The preparative HPLC was used to purify the HYNIC conjugated somatostatin-based peptide and the result showed two peaks, even after two consecutive purifications. Analysis of these peaks by mass spectrometry indicated the presence of hydrazone, produced during preparation conjugate. Further, we have shown that presence of hydrazone really does not matter because under Tc-99m-labeling conditions, hydrazone is hydrolyzed back to HYNIC that then chelates Tc-99m. A HYNIC-peptide conjugate freeze-dried kit was also prepared in a mildly acidic or neutral condition with a final pH of 6-7. The kit was then labeled by Tc-99m and incubated in 100 degrees C for 10 min, and a labeling yield of >95% was obtained. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:805 / 808
页数:4
相关论文
共 6 条
[1]  
ABRAMS MJ, 1990, J NUCL MED, V31, P2022
[2]   EFFECT OF CO-LIGAND ON THE BIODISTRIBUTION OF TC-99M-LABELED HYDRAZINO NICOTINIC-ACID DERIVATIZED CHEMOTACTIC PEPTIDES [J].
BABICH, JW ;
FISCHMAN, AJ .
NUCLEAR MEDICINE AND BIOLOGY, 1995, 22 (01) :25-30
[3]   99mTc-labeling of hydrazones of a hydrazinonicotinamide conjugated cyclic peptide [J].
Edwards, DS ;
Liu, S ;
Harris, AR ;
Poirier, MJ ;
Ewels, BA .
BIOCONJUGATE CHEMISTRY, 1999, 10 (05) :803-807
[4]  
Gandomkar M., 2006, Daru, V14, P183
[5]   Synthesis of stable hydrazones of a hydrazinonicotinyl-modified peptide for the preparation of 99mTc-labeled radiopharmaceuticals [J].
Harris, TD ;
Sworin, M ;
Williams, N ;
Rajopadhye, M ;
Damphousse, PR ;
Glowacka, D ;
Poirier, MJ ;
Yu, K .
BIOCONJUGATE CHEMISTRY, 1999, 10 (05) :808-814
[6]   Radiopharmaceutical development of a freeze-dried kit formulation for the preparation of [99mTc-EDDA-HYNIC-D-Phe1, Tyr3]-octreotide, a somatostatin analog for tumor diagnosis [J].
Von Guggenberg, E ;
Mikolajczak, R ;
Janota, B ;
Riccabona, G ;
Decristoforo, C .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (10) :2497-2506